Related Experiment Videos
Anti HSV-2 properties of amniotic fluid
F Rossano1, A Rizzo, M R Sanges
1Istituto di Microbiologia, I Facoltà di Medicina e Chirurgia, Università di Napoli, Italy.
Microbiologica
|July 1, 1988
Summary
Amniotic fluid (AF) shows antiviral properties, with a virus-neutralizing activity observed against HSV2. This activity in amniotic fluid may not be solely due to antibodies, suggesting other protective substances are present.
Area of Science:
- Virology
- Immunology
- Obstetrics
Background:
- Amniotic fluid (AF) plays a crucial role in fetal development and protection.
- The presence of antiviral factors in AF is important for protecting the fetus from infections.
- Antibodies in maternal blood and AF share a close relationship, suggesting potential passive immunity transfer.
Purpose of the Study:
- To investigate the antiviral properties of amniotic fluid.
- To determine if antiviral activity in AF is solely antibody-dependent.
- To explore the presence of non-antibody antiviral substances in AF using HSV2 as a model.
Main Methods:
- Collection and analysis of amniotic fluid (AF) specimens.
- Testing AF for virus-neutralizing activity using Herpes Simplex Virus type 2 (HSV2) as a model.
- Comparison of AF antiviral activity with antibody levels.
Main Results:
- A significant virus-neutralizing activity was detected in 6 out of 7 AF specimens studied.
- The observed antiviral activity in AF did not appear to be directly related to antibody content.
- This suggests the presence of non-antibody antiviral substances within amniotic fluid.
Conclusions:
- Amniotic fluid possesses intrinsic antiviral properties beyond antibody-mediated immunity.
- Non-antibody antiviral factors in AF may contribute to protecting the fetus from viral infections.
- Further research is warranted to identify and characterize these novel antiviral substances in AF.